Related Experiment Video

Updated: Aug 15, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Adult cyanotic congenital heart disease

S Prusty, D N Ross

    Thorax
    |December 1, 1975
    PubMed

    Insights

    Surgical repair of adult cyanotic heart disease is feasible despite technical challenges. Most adult patients achieve excellent or good clinical outcomes after corrective surgery, indicating age is not a barrier.

    Area of Science:

    • Cardiology
    • Adult Congenital Heart Disease
    • Cardiac Surgery

    Background:

    • Cyanotic heart disease presents significant surgical challenges in adults due to complex anatomical deformities and physiological compromises.
    • Review of various congenital heart abnormalities and their surgical management in adult patients.

    Purpose of the Study:

    • To evaluate the safety and efficacy of surgical correction for cyanotic heart disease in adult patients.
    • To determine if advanced age precludes complete repair of these cardiac conditions.

    Main Methods:

    • Surgical intervention was performed on 46 adult patients (age > 18 years) with cyanotic heart disease.
    • Outcomes were assessed based on clinical results, categorizing them as excellent, good, or otherwise.

    Main Results:

    • The study reported 10 operative deaths among the 46 patients.
    • Of the surviving patients, 63% achieved an excellent clinical result.
    • Overall, 69.5% of all patients experienced an excellent or good outcome post-surgery.

    Conclusions:

    • Patient age should not be a contraindication for the complete surgical repair of cyanotic heart disease.
    • All adult patients diagnosed with cyanotic heart disease warrant thorough investigation for potential surgical correction.

    More Related Videos

    Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System07:34

    Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

    Published on: May 5, 2018

    Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

    Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

    Published on: March 10, 2020

    Related Concept Videos

    Genetic Lingo01:11

    Genetic Lingo

    Overview
    Imbalances in Cardiac Output01:26

    Imbalances in Cardiac Output

    The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
    CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Continuous Renal Replacement Therapy01:30

    Continuous Renal Replacement Therapy

    Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...